Fuller & Thaler Asset Management Inc. Purchases 190,360 Shares of Plexus Corp. $PLXS

Key Points

• Fuller & Thaler Asset Management Inc. increased its holdings in Plexus Corp. by 120.4%, now owning approximately 1.29% of the company, valued at $44.7 million.
• Multiple institutional investors have significantly boosted their stakes in Plexus, with 94.45% of the company's stock now owned by institutional investors.
• Plexus reported earnings of $1.90 per share, exceeding expectations by $0.19, with revenues of $1.02 billion during the last quarter, representing a year-over-year revenue increase of 6%.

Fuller & Thaler Asset Management Inc. lifted its stake in Plexus Corp. (NASDAQ:PLXS - Free Report) by 120.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 348,510 shares of the technology company's stock after purchasing an additional 190,360 shares during the quarter. Fuller & Thaler Asset Management Inc. owned 1.29% of Plexus worth $44,655,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of PLXS. Aquatic Capital Management LLC raised its position in shares of Plexus by 134.0% in the 4th quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock worth $37,000 after purchasing an additional 134 shares during the last quarter. Versant Capital Management Inc raised its position in shares of Plexus by 1,000.0% in the 1st quarter. Versant Capital Management Inc now owns 473 shares of the technology company's stock worth $61,000 after purchasing an additional 430 shares during the last quarter. TD Private Client Wealth LLC raised its position in shares of Plexus by 185.6% in the 1st quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company's stock worth $66,000 after purchasing an additional 334 shares during the last quarter. N.E.W. Advisory Services LLC purchased a new position in shares of Plexus in the 1st quarter worth about $87,000. Finally, Blue Trust Inc. raised its position in shares of Plexus by 49.2% in the 1st quarter. Blue Trust Inc. now owns 846 shares of the technology company's stock worth $108,000 after purchasing an additional 279 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Needham & Company LLC lowered their price target on Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research report on Thursday, July 24th. Benchmark reissued a "buy" rating and issued a $160.00 target price on shares of Plexus in a research report on Wednesday, June 4th. Wall Street Zen lowered Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Stifel Nicolaus set a $140.00 target price on Plexus in a research report on Thursday, July 24th. Finally, Sidoti raised Plexus from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $135.00 to $150.00 in a research report on Friday, July 25th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Plexus presently has an average rating of "Moderate Buy" and a consensus price target of $152.00.

Insider Buying and Selling at Plexus

In other Plexus news, Director Karen Marie Rapp sold 500 shares of the business's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $130.77, for a total transaction of $65,385.00. Following the completion of the sale, the director directly owned 9,365 shares in the company, valued at $1,224,661.05. The trade was a 5.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of the business's stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $125.63, for a total value of $188,445.00. Following the sale, the chief executive officer owned 72,214 shares of the company's stock, valued at approximately $9,072,244.82. This represents a 2.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 12,484 shares of company stock worth $1,626,335. 1.76% of the stock is owned by corporate insiders.

Plexus Stock Performance

NASDAQ:PLXS traded up $6.71 during mid-day trading on Friday, reaching $137.26. The company's stock had a trading volume of 151,618 shares, compared to its average volume of 159,419. Plexus Corp. has a 12-month low of $103.43 and a 12-month high of $172.89. The firm's fifty day moving average price is $132.44 and its two-hundred day moving average price is $129.98. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The stock has a market cap of $3.70 billion, a P/E ratio of 23.38 and a beta of 0.80.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.19. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the firm earned $1.45 EPS. Plexus's revenue was up 6.0% on a year-over-year basis. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, equities analysts forecast that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.